Sunitix 12.5mg (Sunitinib)

Description

About Sunitix 12.5mg (Sunitinib)

This medication is an example of a targeted therapy class of drugs that is known as a cancer growth inhibitor. This medicine is effective because it blocks certain signals, which in turn stops the growth of cancer cells. This remedy has the formula C22H27FN4O2 in its chemical make-up. The percentage of its protein bond is 95%. Beacon pharmaceutical LTD is the company that is responsible for the production and distribution of this medication.

Dosage

If you have advanced renal cell carcinoma or gastrointestinal stromal tumor (GIST), you need to take one oral dose of 50 milligrams of the medication (RCC). You can take it either with food or on an empty stomach. This Sunitix dosage of 12.5 milligrams is typically used for modifying the dosage of your cancer treatment.

Side Effects 

• Bleeding gums.
• a puffy appearance or swelling of the face, arms, hands, fingers, lower legs, or feet may be present.
• chest pain.
• blood coming up in the cough.
• lips that are split.
• decreased urine output as well as the frequency of urination.

Storage

This medication should be kept at room temperature. This should not be exposed to any moisture or temperatures higher than 25 degrees celsius.